Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial thyroid dyshormonogenesis in which the cause of the disease is a mutation in the DUOXA2 gene.
Features include: Abnormality of metabolism/homeostasis, Hypothyroidism, Growth delay, and Goiter and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Metabolism | 1 | Abnormality of metabolism/homeostasis |
Hormones |
DUOXA2 encodes dual oxidase maturation factor 2 (320 aa). Required for the maturation and transport of functional DUOX2 from the endoplasmic reticulum to the plasma membrane. Recruits DUOX2 to the apical cell membrane Highest expression in Thyroid (25.5 TPM) and Vagina (7.4 TPM).
Thyroid dyshormonogenesis 5 is associated with mutations in the DUOXA2 gene on chromosome 15.
The DUOXA2 protein participates in Pancreatic pro-acinar cell produces pancreatic acinar cell pathway.
DUOXA2 is classified as a druggable target with score 0.0.
Genetic testing for DUOXA2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for thyroid dyshormonogenesis 5 has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
15 publications have been identified in PubMed for thyroid dyshormonogenesis 5. Research spans Basic Science / Preclinical (67%), Case Report / Case Series (20%), and Diagnostic / Biomarker (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 10 | 67% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 3:54 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1
Hypothyroidism |
Growth and development | 1 | Growth delay |
Brain and nerves | 1 | Intellectual disability |
Patient case studies |
3 |
20% |
Testing and diagnosis research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Islam MS (2026). [PMID: 41004687](https://pubmed.ncbi.nlm.nih.gov/41004687/). *The Journal of clinical endocrinology and metabolism*. [Basic Science / Preclinical]
Kurnaz E (2026). [PMID: 39378853](https://pubmed.ncbi.nlm.nih.gov/39378853/). *Hormone research in paediatrics*. [Basic Science / Preclinical]
Dalal A (2025). [PMID: 38986456](https://pubmed.ncbi.nlm.nih.gov/38986456/). *Hormone research in paediatrics*. [Basic Science / Preclinical]
Trivedi V (2025). [PMID: 40440572](https://pubmed.ncbi.nlm.nih.gov/40440572/). *JCO global oncology*. [Case Report / Case Series]
Islam MS (2025). [PMID: 40956475](https://pubmed.ncbi.nlm.nih.gov/40956475/). *Endocrine*. [Case Report / Case Series]
Ricci V (2025). [PMID: 41262259](https://pubmed.ncbi.nlm.nih.gov/41262259/). *Frontiers in endocrinology*. [Basic Science / Preclinical]
Wang F (2025). [PMID: 40071799](https://pubmed.ncbi.nlm.nih.gov/40071799/). *Endokrynologia Polska*. [Diagnostic / Biomarker]
Zhou B (2025). [PMID: 40372221](https://pubmed.ncbi.nlm.nih.gov/40372221/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Case Report / Case Series]
Hirano Y (2025). [PMID: 40986648](https://pubmed.ncbi.nlm.nih.gov/40986648/). *European journal of endocrinology*. [Basic Science / Preclinical]
Ahn J (2025). [PMID: 40362701](https://pubmed.ncbi.nlm.nih.gov/40362701/). *International journal of molecular sciences*. [Basic Science / Preclinical]